Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib)
- 2 June 2017
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 35 (30), 3764-3772
- https://doi.org/10.1016/j.vaccine.2017.05.043
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve MonthsThe Pediatric Infectious Disease Journal, 2017
- Lot-to-lot Consistency, Safety, Tolerability and Immunogenicity of an Investigational Hexavalent Vaccine in US InfantsThe Pediatric Infectious Disease Journal, 2017
- A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11–12 monthsVaccine, 2016
- Immunogenicity, Safety, and Tolerability of a Hexavalent Vaccine in InfantsPEDIATRICS, 2015
- The value of childhood combination vaccines: From beliefs to evidenceHuman Vaccines & Immunotherapeutics, 2015
- Safety and Immunogenicity of a Meningococcal Quadrivalent Conjugate Vaccine in Five- to Eight-Year-Old Saudi Arabian Children Previously Vaccinated with Two Doses of a Meningococcal Quadrivalent Polysaccharide VaccineClinical and Vaccine Immunology, 2012
- Use of Combination Vaccines Is Associated With Improved Coverage RatesThe Pediatric Infectious Disease Journal, 2007
- The Use of Combination Vaccines Has Improved Timeliness of Vaccination in ChildrenThe Pediatric Infectious Disease Journal, 2006
- Environmentally and Occupationally Acquired Diseases in Adolescents and Adulthood: Control of Diphtheria, Tetanus, Pertussis, and Poliomyelitis through Regular Booster Vaccinations-a European PerspectiveReviews on Environmental Health, 2005
- The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae Type bThe Journal of Infectious Diseases, 1983